These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16723785)

  • 1. Randomized crossover study of the long-term effects of pilsicainide and cibenzoline in preventing recurrence of symptomatic paroxysmal atrial fibrillation: influence of the duration of arrhythmia before therapy.
    Komatsu T; Sato Y; Tachibana H; Nakamura M; Horiuchi D; Okumura K
    Circ J; 2006 Jun; 70(6):667-72. PubMed ID: 16723785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized study on the efficacy of intravenous cibenzoline and pilsicainide administered prior to electrical cardioversion in patients with lone paroxysmal and persistent atrial fibrillation.
    Komatsu T; Tachibana H; Sato Y; Ozawa M; Ohshima K; Orii M; Kunigida F; Nakamura M
    J Cardiol; 2009 Feb; 53(1):35-42. PubMed ID: 19167636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship between long-term preventive efficacy of cibenzoline and atrial natriuretic peptide in patients with paroxysmal atrial fibrillation].
    Komatsu T; Nakamura S; Kimura M; Owada S; Yomogida K; Kameda K; Oikawa K; Tomita H; Okumura K
    J Cardiol; 2002 Feb; 39(2):93-9. PubMed ID: 11873440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of amiodarone for preventing the recurrence of symptomatic paroxysmal and persistent atrial fibrillation after cardioversion.
    Komatsu T; Tachibana H; Sato Y; Ozawa M; Nakamura M; Okumura K
    Circ J; 2007 Jan; 71(1):46-51. PubMed ID: 17186977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilsicainide for conversion and maintenance of sinus rhythm in chronic atrial fibrillation: a placebo-controlled, multicenter study.
    Okishige K; Nishizaki M; Azegami K; Igawa M; Yamawaki N; Aonuma K;
    Am Heart J; 2000 Sep; 140(3):e13. PubMed ID: 10966544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilsicainide.
    Plosker GL
    Drugs; 2010 Mar; 70(4):455-67. PubMed ID: 20205487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological conversion of persistent atrial fibrillation into sinus rhythm with oral pilsicainide: pilsicainide suppression trial for persistent atrial fibrillation II.
    Okishige K; Fukunami M; Kumagai K; Atarashi H; Inoue H;
    Circ J; 2006 Jun; 70(6):657-61. PubMed ID: 16723783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of pilsicainide for the long-term prevention of paroxysmal atrial fibrillation: analysis based on the time of onset].
    Komatsu T; Nakamura S; Kimura M; Owada S; Tomita H; Yomogida K; Okumura K
    J Cardiol; 2001 Oct; 38(4):211-7. PubMed ID: 11688428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of cibenzoline in the termination and long-term prevention of paroxysmal atrial fibrillation: analysis based on the time of onset].
    Komatsu T; Nakamura S; Kimura M; Owada S; Saito E; Kobayashi T; Okumura K
    J Cardiol; 2001 Feb; 37(2):75-82. PubMed ID: 11255698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cibenzoline versus flecainide in the prevention of paroxysmal atrial arrhythmias: a double-blind randomized study.
    Babuty D; D'Hautefeuille B; Scheck F; Mycinsky C; Pruvost P; Peraudeau P
    J Clin Pharmacol; 1995 May; 35(5):471-7. PubMed ID: 7657846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of recent-onset Atrial Fibrillation by a single oral dose of Pilsicainide (Pilsicainide Suppression Trial on atrial fibrillation). The PSTAF Investigators.
    Atarashi H; Inoue H; Hiejima K; Hayakawa H
    Am J Cardiol; 1996 Sep; 78(6):694-7. PubMed ID: 8831412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between duration of arrhythmia and subsequent preventive effect of disopyramide after cardioversion in patients with symptomatic paroxysmal and persistent atrial fibrillation].
    Komatsu T; Yomogida K; Nakamura S; Suzuki O; Horiuchi D; Kameda K; Tomita H; Abe N; Owada S; Oikawa K; Okumura K
    J Cardiol; 2003 Sep; 42(3):111-7. PubMed ID: 14526660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
    Pappone C; Augello G; Sala S; Gugliotta F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Sora N; Greiss I; Santagostino A; LiVolsi L; Pappone N; Radinovic A; Manguso F; Santinelli V
    J Am Coll Cardiol; 2006 Dec; 48(11):2340-7. PubMed ID: 17161267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of cibenzoline and flecainide by oral route for preventing recurrence of paroxysmal atrial tachyarrhythmias].
    Maison-Blanche P; Brembilla-Perrot B; Fauchier JP; Babuty D; Garnier LF; Rouesnel P; Breuillac JC; Funck F; Scheck F; Peraudeau P; Medvedowsky JL
    Ann Cardiol Angeiol (Paris); 1997 Feb; 46(2):109-16. PubMed ID: 9137677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of antiarrhythmic drug therapy in preventing recurrence of atrial fibrillation and long-term cardiovascular prognosis in patients with asymptomatic paroxysmal atrial fibrillation.
    Komatsu T; Tachibana H; Sato Y; Ozawa M; Kunugida F; Nakamura M
    Int Heart J; 2010 Mar; 51(2):98-104. PubMed ID: 20379042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative effects of cibenzoline and hydroquinidine in the prevention of auricular fibrillation. A randomized double-blind study].
    Touboul P; Brembilla-Perrot B; Scheck F; Gabriel A; Lardoux H; Marchand X; Levy S
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):525-31. PubMed ID: 8745663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose flecainide infusion followed by oral pilsicainide is highly effective and safe for paroxysmal atrial fibrillation.
    Nagai S; Takeishi Y; Kubota I
    Cardiovasc Drugs Ther; 2003 Jan; 17(1):95-7. PubMed ID: 12916520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of bepridil on paroxysmal atrial fibrillation: relationship between efficacy and the f-f interval in surface ECG recordings.
    Yoshida T; Niwano S; Inuo K; Saito J; Kojima J; Ikeda-Murakami K; Hara H; Izumi T
    Circ J; 2003 Jan; 67(1):11-5. PubMed ID: 12520144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance.
    Galperín J; Elizari MV; Chiale PA; Molina RT; Ledesma R; Scapín AO; Blanco MV; Bonato R; Lago M;
    J Cardiovasc Pharmacol Ther; 2003 Sep; 8(3):179-86. PubMed ID: 14506542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.